The CEO of Moderna recently addressed pressing concerns regarding bioterrorism and Europe's readiness for potential future pandemics.
Moderna, widely recognized for its life-saving COVID-19 vaccine, is reportedly exploring various initiatives related to pandemic preparedness and cancer treatments.
This discussion highlights the importance of ongoing vigilance and innovation in public health strategies to combat emerging threats.